Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience

Bone Marrow Transplantation volume 47, pages 867–868 (2012)Cite this article

G-CSF filgrastim is frequently used to mobilise CD34+ cells in donors before PBSC collection. Several observational reports raised concerns regarding an elevated risk of haematological malignancies after G-CSF administration. It was found that treatment with G-CSF of PBSC donors induced chromosomal tetraploidy in a small subset of mature myeloid cells in the blood,1 epigenetic and genetic alterations in lymphocytes2 and aneuploidy.3 In 2006, Bennett et al.4 reported two cases of AML identified in the sibling donors, whose recipients also suffered with AML, among 200 individuals who had received filgrastim before collection of PBSC for allogeneic transplantation. In a large retrospective EBMT analysis, Halter et al.5 observed 20 haematological malignancies (3.92/10 000), of which 12 were after donating PBSC; however, the observed incidence rate did not exceed the expected incidence in an age- and sex-adjusted general population, and there was no relationship with the type of haematological malignancy in the recipients and donors donating for siblings.

We decided to conduct an analysis of follow-up policy and haematological malignancy incidence in related sibling donors of allogeneic PBSC mobilised with G-CSF filgrastim in the period of 2001–2010 at our transplant centre (TC), and to compare the results with those of unrelated donors of the Czech National Marrow Donor Registry (CNMDR).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kaplinsky C, Trakhtenbrot L, Hardan I, Reichart MM, Daniely M, Toren A et al. Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF. Bone Marrow Transplant 2003; 32: 31–34.

    Article  CAS  Google Scholar 

  2. Nagler A, Korenstein-Ilan A, Amiel A, Avivi L . Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol 2004; 32: 122–130.

    Article  CAS  Google Scholar 

  3. Marmier-Savet C, Larosa F, Legrand F, Witz B, Michallet M, Ranta D et al. G-CSF–induced aneuploidy does not affect CD34+ cells and does not require cell division. Blood 2010; 115: 910–911.

    Article  CAS  Google Scholar 

  4. Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol 2006; 135: 642–650.

    Article  CAS  Google Scholar 

  5. Halter J, Kodera Y, Urbano Ispizua A, Greinix HT, Schmitz N, Favre G . Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 2009; 94: 94–101.

    Article  Google Scholar 

  6. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, Cancer statistics, Database: Incidence—SEER 17 (2000–2008), www.seer.cancer.gov (accessed on 20 June 2011).

  7. Pottern LM, Linet M, Blair A, Dick F, Burmeister LF, Gibson R et al. Familial cancers associated with subtypes of leukemia and non-Hodgkins lymphoma. Leuk Res 1991; 15: 305–314.

    Article  CAS  Google Scholar 

  8. Segel GB, Lichtman MA . Familial (inherited) leukemia, lymphoma, and myeloma: an overview. Blood Cells, Mol Dis 2004; 32: 246–261.

    Article  Google Scholar 

  9. Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 109: 3479–3488.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haemato-Oncology, University Hospital, Plzen (Pilsen), Czech Republic

    S Vokurka, V Koza, A Jungova, J Navratilova, T Svoboda, P Jindra, K Steinerova & R Vyrutova

Authors
  1. S Vokurka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V Koza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Jungova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Navratilova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Svoboda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Jindra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K Steinerova
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R Vyrutova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Vokurka.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vokurka, S., Koza, V., Jungova, A. et al. Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience. Bone Marrow Transplant 47, 867–868 (2012). https://doi.org/10.1038/bmt.2011.173

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.173

Search

Advanced search

Quick links